3,447 Shares in Astera Labs, Inc. $ALAB Purchased by J.Safra Asset Management Corp

J.Safra Asset Management Corp acquired a new position in Astera Labs, Inc. (NASDAQ:ALAB) during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 3,447 shares of the company’s stock, valued at approximately $1,665,000.

A number of other institutional investors and hedge funds have also made changes to their positions in ALAB. Eurizon Capital SGR S.p.A. purchased a new position in Astera Labs during the fourth quarter valued at $18,708,000. Swedbank AB grew its stake in shares of Astera Labs by 76.8% in the fourth quarter. Swedbank AB now owns 78,140 shares of the company’s stock worth $12,999,000 after acquiring an additional 33,940 shares during the last quarter. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. bought a new position in shares of Astera Labs during the fourth quarter valued at $499,000. Revere Asset Management Inc bought a new position in shares of Astera Labs during the fourth quarter valued at $589,000. Finally, Banque Cantonale Vaudoise raised its position in shares of Astera Labs by 85.9% in the 1st quarter. Banque Cantonale Vaudoise now owns 6,990 shares of the company’s stock worth $766,000 after purchasing an additional 3,229 shares during the last quarter. Institutional investors own 60.47% of the company’s stock.

Astera Labs Price Performance

ALAB stock opened at $321.61 on Monday. Astera Labs, Inc. has a 1-year low of $97.89 and a 1-year high of $499.48. The business has a fifty day moving average price of $358.00 and a 200-day moving average price of $240.74. The stock has a market capitalization of $55.80 billion, a P/E ratio of 159.21 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The firm had revenue of $392.40 million for the quarter, compared to the consensus estimate of $360.85 million. During the same period in the prior year, the company posted $0.44 earnings per share. The company’s quarterly revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, analysts anticipate that Astera Labs, Inc. will post 2.7 earnings per share for the current year.

Insider Buying and Selling at Astera Labs

In other news, Director Manuel Alba sold 136,974 shares of Astera Labs stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $442.01, for a total value of $60,543,877.74. Following the completion of the sale, the director directly owned 1,287,524 shares in the company, valued at $569,098,483.24. The trade was a 9.62% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Jack R. Lazar sold 10,000 shares of the business’s stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the transaction, the director directly owned 75,688 shares of the company’s stock, valued at $26,882,106.96. The trade was a 11.67% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 940,716 shares of company stock worth $292,425,777. 10.40% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on the stock. Roth Capital reiterated a “buy” rating and issued a $450.00 price target on shares of Astera Labs in a research note on Wednesday, August 5th. Weiss Ratings upgraded shares of Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, May 21st. Evercore reaffirmed an “outperform” rating and issued a $297.00 target price on shares of Astera Labs in a report on Tuesday, May 19th. Zacks Research upgraded shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 11th. Finally, Rothschild & Co Redburn started coverage on shares of Astera Labs in a report on Friday, May 1st. They set a “neutral” rating and a $153.00 price target on the stock. One investment analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $325.25.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.